Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (71-80 of 350) with videos related to

Pageof 35
Sort By:
Clinical Colorectal Cancer|April 6, 2005
The assessment and management of cancer treatment-related diarrheaBridget E O'Brien, Virginia G Kaklamani, Al B Benson
Gastroenterology & Hepatology|June 23, 2010
A multidisciplinary approach to the management of hepatocellular carcinomaRobert G Gish, Jorge A Marrero, Al B Benson
Oncology (Williston Park, N.Y.)|February 15, 2012
Have the changes in treatment of rectal cancer made a significant difference to our patients?Al B Benson, José G Guillem, Bruce D Minsky
Clinical Colorectal Cancer|July 21, 2010
The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settingsPolina Khrizman, William Small, Laura Dawson, et al.
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
Panitumumab in metastatic colorectal cancerKari B Wisinski, Mary F Mulcahy, Al B Benson
Expert Opinion on Biological Therapy|May 5, 2007
Bevacizumab in the treatment of colorectal cancerJeffrey C Cilley, Keren Barfi, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Effect of the accountable care act of 2010 on clinical trial insurance coverageSheetal M Kircher, Al B Benson, Matthew Farber, et al.
Oncology (Williston Park, N.Y.)|January 9, 2008
Inoperable pancreatic cancer: standard of careKari B Wisinski, Andrew O Wahl, William Small, et al.
Molecular Diagnosis & Therapy|April 22, 2008
The role of molecular markers in predicting response to therapy in patients with colorectal cancerVeena Shankaran, Kari B Wisinski, Mary F Mulcahy, et al.
Journal of Medical Economics|May 10, 2018
First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USAMichael S Broder, Beilei Cai, Eunice Chang, et al.
Pageof 35

Showing results (71-80 of 350) with videos related to

Sort By:
Pageof 35
Clinical Colorectal Cancer|April 6, 2005
The assessment and management of cancer treatment-related diarrheaBridget E O'Brien, Virginia G Kaklamani, Al B Benson
Gastroenterology & Hepatology|June 23, 2010
A multidisciplinary approach to the management of hepatocellular carcinomaRobert G Gish, Jorge A Marrero, Al B Benson
Oncology (Williston Park, N.Y.)|February 15, 2012
Have the changes in treatment of rectal cancer made a significant difference to our patients?Al B Benson, José G Guillem, Bruce D Minsky
Clinical Colorectal Cancer|July 21, 2010
The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settingsPolina Khrizman, William Small, Laura Dawson, et al.
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
Panitumumab in metastatic colorectal cancerKari B Wisinski, Mary F Mulcahy, Al B Benson
Expert Opinion on Biological Therapy|May 5, 2007
Bevacizumab in the treatment of colorectal cancerJeffrey C Cilley, Keren Barfi, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Effect of the accountable care act of 2010 on clinical trial insurance coverageSheetal M Kircher, Al B Benson, Matthew Farber, et al.
Oncology (Williston Park, N.Y.)|January 9, 2008
Inoperable pancreatic cancer: standard of careKari B Wisinski, Andrew O Wahl, William Small, et al.
Molecular Diagnosis & Therapy|April 22, 2008
The role of molecular markers in predicting response to therapy in patients with colorectal cancerVeena Shankaran, Kari B Wisinski, Mary F Mulcahy, et al.
Journal of Medical Economics|May 10, 2018
First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USAMichael S Broder, Beilei Cai, Eunice Chang, et al.
Pageof 35